Skip to main content

Table 7 Age and sex-specific distribution of PhenX WHO CIDI-SF major depression episode (MDE) and comparison with published data

From: Validation of PhenX measures in the personalized medicine research project for use in gene/environment studies

Male

Female

Study

Age 50-64

Age 65+

Age 50-64

Age 65+

MDE% (9.5% CL)

MDE% (95% CL)

MDE% (95% CL)

MDE% (95% CL)

PhenX

14.2 (9.5, 18.8)

8.8 (6.7, 11.0)

31.3 (26.6, 36.1)

11.9 (9.8, 14.0)

NCR-R*

16.2 (13.5, 18.9)

5.3 (2.9, 7.7)

24.6 (21.7, 27.5)

13.0 (10.5. 15.5)

  1. *National Comorbidity Surveys Replication, Kessler et al. 2010 [8].